Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgeon vs Anesthesiologist Adductor Canal Block in TKA
NCT03864588Phase 4Unknown
- Sponsor
- Rothman Orthopaedics
- Start
- Oct 2018
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Rothman Orthopaedics. Primary endpoint: Visual Analog Scale at 6 weeks. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03864588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03864588.